Atlas Trials

Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy

Clinical trial NCT00664027 · COMPLETED

Trial details

NCT number
NCT00664027
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Nephropathy
Start date
2008-04-30
Primary completion
2009-05-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.